Fulgent Genetics Inc.

NASDAQ: FLGT · Real-Time Price · USD
21.74
-0.03 (-0.14%)
At close: Aug 14, 2025, 3:59 PM
21.74
0.00%
After-hours: Aug 14, 2025, 04:20 PM EDT

Fulgent Genetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
283.47M 289.21M 618.97M 992.58M
Cost of Revenue
176.25M 184.76M 252.07M 215.53M
Gross Profit
107.22M 104.46M 366.9M 777.05M
Operating Income
-73.92M -195.53M 178.53M 675.95M
Interest Income
31.3M 21.44M 5.62M 1.35M
Pretax Income
-51.96M -174.09M 184.03M 677.3M
Net Income
-42.71M -167.82M 143.4M 507.36M
Selling & General & Admin
124.35M 130.47M 149.99M 75.17M
Research & Development
48.82M 41.44M 28.91M 24.22M
Other Expenses
7.96M 128.08M 9.47M 1.71M
Operating Expenses
181.13M 299.4M 188.37M 101.1M
Interest Expense
170K 488K 1.01M n/a
Selling & Marketing Expenses
36.25M 41.47M 38.92M 24.44M
Cost & Expenses
357.39M 484.74M 437.47M 316.63M
Income Tax Expense
-8.14M 1.15M 42.1M 174.79M
Shares Outstanding (Basic)
30.23M 29.78M 30.1M 29.41M
Shares Outstanding (Diluted)
30.23M 29.78M 30.96M 30.98M
EPS (Basic)
-1.41 -5.63 4.76 17.13
EPS (Diluted)
-1.41 -5.63 4.63 16.26
EBITDA
-48.99M -46.55M 221.59M 686.96M
EBIT
-73.92M -173.6M 184.68M 677.3M
Depreciation & Amortization
24.93M 26.14M 36.91M 11M